Recreational Cannabis Legalization and Opioid-Related Deaths in Colorado, 2000-2015.
other · Level IV
Where this comes from
- Record sourced from PubMed, PMID 29019782.
- Also identified by DOI 10.2105/AJPH.2017.304059 and PMC identifier 5637677.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To examine the association between Colorado's legalization of recreational cannabis use and opioid-related deaths. We used an interrupted time-series design (2000-2015) to compare changes in level and slope of monthly opioid-related deaths before and after Colorado stores began selling recreational cannabis. We also describe the percent change in opioid-related deaths by comparing the unadjusted model-smoothed number of deaths at the end of follow-up with the number of deaths just prior to legalization. Colorado's legalization of recreational cannabis sales and use resulted in a 0.7 deaths per month (b = -0.68; 95% confidence interval = -1.34, -0.03) reduction in opioid-related deaths. This reduction represents a reversal of the upward trend in opioid-related deaths in Colorado. Legalization of cannabis in Colorado was associated with short-term reductions in opioid-related deaths. As additional data become available, research should replicate these analyses in other states with legal recreational cannabis.
Medical subject headings
- Marijuana Smoking
- Opioid-Related Disorders